Literature DB >> 8432479

DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases.

M J Brito1, M I Filipe, G T Williams, H Thompson, M G Ormerod, J Titley.   

Abstract

DNA ploidy of 100 early gastric carcinomas (T1) was analysed by flow cytometry on archival material from five European centres and was correlated to morphological features and clinical behaviour. Tumours were classified according to the macroscopic appearance, histological type, and growth pattern. Aneuploidy was observed in 39% of tumours. Aneuploidy was more frequent in submucosal than in mucosal tumours (p = 0.04), in raised than in flat or ulcerated lesions (p = 0.001), and in the intestinal histological than in the diffuse types (p = 0.016). The presence of lymph node metastasis in 10 cases had no obvious relation to DNA ploidy. Five related deaths occurred during the follow up (6 months--16 years) of 84 patients. These results are similar to those reported in a large Japanese series suggesting no major differences between the two populations. Although follow up data were insufficient to relate DNA ploidy to tumour behaviour in this study, the Japanese experience shows that particular attention should be paid to early direction and complete surgical excision of raised intestinal type T1 carcinomas that have a Pen A growth pattern and are aneuploid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432479      PMCID: PMC1373976          DOI: 10.1136/gut.34.2.230

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Flow cytometric analysis of DNA ploidy pattern from deparaffinized formalin-fixed gastric cancer tissue.

Authors:  P Tosi; L Leoncini; M Cintorino; C Vindigni; C Minacci; S Nuti; E Pinto; A de Stefano; G Cevenini
Journal:  Int J Cancer       Date:  1988-12-15       Impact factor: 7.396

3.  Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas.

Authors:  K Sasaki; T Hashimoto; K Kawachino; M Takahashi
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

4.  Differentiation of growth patterns of early gastric carcinoma determined by cytophotometric DNA analysis.

Authors:  K Inokuchi; Y Kodama; O Sasaki; T Kamegawa; T Okamura
Journal:  Cancer       Date:  1983-03-15       Impact factor: 6.860

5.  Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis.

Authors:  H Kimura; Y Yonemura
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

6.  Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types.

Authors:  Y Kodama; K Inokuchi; K Soejima; T Matsusaka; T Okamura
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

7.  Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.

Authors:  Y Yonemura; S Ooyama; K Sugiyama; T Kamata; X De Aretxabala; H Kimura; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

8.  Correlation of DNA ploidy and clinical outcome in early gastric carcinomas.

Authors:  Y Yonemura; K Sugiyama; T Kamata; T Kosaka; A Yamaguchi; K Miwa; X De Aretxeblala; I Miyazaki
Journal:  Oncology       Date:  1990       Impact factor: 2.935

9.  DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer.

Authors:  D Korenaga; T Okamura; A Saito; H Baba; K Sugimachi
Journal:  Cancer       Date:  1988-07-15       Impact factor: 6.860

10.  Flow cytometric analysis of the DNA content of gastric cancer.

Authors:  K C Ballantyne; P D James; R A Robins; R W Baldwin; J D Hardcastle
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

View more
  7 in total

Review 1.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

2.  Relationship of Helicobacter pylori to Bcl-2 family expression, DNA content, and pathological characteristics of gastric cancer.

Authors:  Mohamed El-Shahat; Samir El-Masry; Mahmoud Lotfy; Ayman El-Meghawry El-Kenawy; Wesam A Nasif
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa.

Authors:  M J Brito; G T Williams; H Thompson; M I Filipe
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

4.  Lifestyle chemical carcinogens associated with mutations in cell cycle regulatory genes increases the susceptibility to gastric cancer risk.

Authors:  Ravi Prakash Yadav; Souvik Ghatak; Payel Chakraborty; Freda Lalrohlui; Ravi Kannan; Rajeev Kumar; Jeremy L Pautu; John Zomingthanga; Saia Chenkual; Rajendra Muthukumaran; Nachimuthu Senthil Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2018-09-12       Impact factor: 4.223

5.  Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia.

Authors:  C M Gleeson; J M Sloan; D T McManus; P Maxwell; K Arthur; J A McGuigan; A J Ritchie; S E Russell
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

6.  DNA analysis by flow cytometry in early gastric cancer.

Authors:  J M Kim; D K Lee; Y K Kim; S K Baik; C I Lee; S O Kwon; S H Jung
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

7.  Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival.

Authors:  J A M Belien; T E Buffart; A J Gill; M A M Broeckaert; P Quirke; G A Meijer; H I Grabsch
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.